Literature DB >> 24398489

Isolated traumatic neurogenic ptosis with delayed recovery.

Khami Satchi1, Anupma Kumar, Alan A McNab.   

Abstract

PURPOSE: To describe the entity of isolated neurogenic ptosis due to presumed tractional injury to the nerve of innervation of the levator palpebrae superioris, with recovery occurring over a period up to 6 months.
METHODS: Retrospective case review.
RESULTS: Three cases of presumed neurapraxic injury to the nerve of innervation to the levator palpebrae superioris are described. Two cases had a clear history of traction to the upper eyelid. There was no evidence of damage to other extraocular muscles or their nerves of innervation in 2 cases and mild transient superior rectus underaction in 1. Maximal recovery occurred over a period of up to 6 months.
CONCLUSIONS: Traumatic neurapraxic injury to the nerve of innervation to the levator palpebrae superioris may occur in certain types of upper eyelid injury, most notably when there is significant forward traction applied to the upper eyelid. Although recovery may occur within weeks, as previously described, this series illustrates that recovery may take up to 6 months.

Entities:  

Mesh:

Year:  2014        PMID: 24398489     DOI: 10.1097/IOP.0000000000000010

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  Traumatic Ptosis: Evaluation of Etiology, Management and Prognosis.

Authors:  Sarah Mireles Jacobs; Ariel J Tyring; Arash J Amadi
Journal:  J Ophthalmic Vis Res       Date:  2018 Oct-Dec

2.  Transient traumatic isolated neurogenic ptosis after a mild head trauma: a case report.

Authors:  Guichen Li; Yang Zhang; Xiaobo Zhu; Kun Hou
Journal:  BMC Ophthalmol       Date:  2015-11-08       Impact factor: 2.209

Review 3.  Spontaneous resolution of isolated neurogenic blepharoptosis after blunt trauma: A case report and literature review.

Authors:  Tae Gi Kim; Jae Ho Shin
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.